Special Issue

Topic: Applications and Future Prospects of AI in Cancer

A Special Issue of Journal of Cancer Metastasis and Treatment

ISSN 2454-2857 (Online) 2394-4722 (Print)

Submission deadline: 22 Dec 2024

Guest Editor(s)

Prof. Pier Paolo Piccaluga
Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Prof. Ciro Isidoro
Department of Health Sciences, Università del Piemonte Orientale "A. Avogadro", Novara, Italy.

Special Issue Introduction

Artificial intelligence (AI) has emerged as a powerful tool in various fields, and its application in cancer research holds immense promise for revolutionizing diagnosis, treatment, and prognosis. This Special Issue aims to delve into the multifaceted landscape of AI in cancer, exploring its current applications and potential future prospects.

AI algorithms, including machine learning and deep learning techniques, have demonstrated remarkable capabilities in analyzing complex datasets, identifying patterns, and making predictions. In the context of cancer, AI has shown promise in areas such as medical imaging analysis, genomics, drug discovery, and personalized medicine.

Medical imaging plays a crucial role in cancer diagnosis and treatment planning. AI-powered algorithms can assist radiologists in detecting tumors, assessing tumor characteristics, and predicting treatment responses based on imaging data. Moreover, AI-driven image analysis has the potential to enhance early detection and improve patient outcomes.

In the era of precision medicine, AI holds the key to unlocking personalized treatment strategies tailored to individual patients. By analyzing genomic and molecular data, AI algorithms can identify biomarkers, predict therapeutic responses, and guide treatment decisions, thereby optimizing patient care and outcomes.

Furthermore, AI-driven approaches have the potential to accelerate drug discovery and development processes, leading to the identification of novel therapeutic targets and the repurposing of existing drugs for cancer treatment. Through data integration and predictive modeling, AI can streamline preclinical research, clinical trials, and drug repurposing efforts, ultimately expediting the translation of scientific discoveries into clinical practice.

Despite the remarkable progress achieved thus far, challenges remain in harnessing the full potential of AI in cancer research. Ethical considerations, data privacy concerns, and the need for robust validation and regulation pose significant hurdles to overcome. Moreover, ensuring equitable access to AI-driven technologies and addressing disparities in data quality and availability are critical for realizing the promise of AI in cancer care.

In this Special Issue, we invite contributions that explore the diverse applications of AI in cancer research, including but not limited to:
- AI-based medical imaging analysis for cancer diagnosis and treatment planning;
- Predictive modeling of treatment responses and outcomes using AI algorithms;
- Integration of genomic and molecular data for personalized cancer therapy;
- AI-driven drug discovery and repurposing efforts in oncology;
- Ethical, legal, and social implications of AI in cancer care.

Through this interdisciplinary exploration, we aim to advance our understanding of the role of AI in cancer research and pave the way for transformative advancements in cancer diagnosis, treatment, and management.

Submission Deadline

22 Dec 2024

Submission Information

For Author Instructions, please refer to https://www.oaepublish.com/jcmt/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=jcmt&SpecialIssueId=jcmt20240516
Submission Deadline: 22 Dec 2024
Contacts: Frida Xu, Assistant Editor, frida-editor@jcmtjournal.com

Published Articles

Coming soon
Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)


All published articles are preserved here permanently:



All published articles are preserved here permanently: